Showing results (351-360 of 563) with videos related to

Sort By:
Pageof 57
EJNMMI Research|October 16, 2020
[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trialGiulia Polverari, Francesco Ceci, Roberto Passera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center StudyIda Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
JAMIA Open|June 29, 2026
Accuracy of administrative data in ascertaining health conditions: a systematic reviewAlexander C Campbell, Jessica Tyler, Rebecca R Shuttleworth, et al.
Health & Justice|April 16, 2024
Correction to: A rapid review of early guidance to prevent and control COVID-19 in custodial settingsLindsay A Pearce, Alaina Vaisey, Claire Keen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2019
Can the Injected Dose Be Reduced in <sup>68</sup>Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?Isabel Rauscher, Wolfgang P Fendler, Thomas A Hope, et al.
Cytokine|January 8, 2019
Lifelong exercise practice and immunosenescence: Master athletes cytokine response to acute exerciseLuciele Guerra Minuzzi, Matheus Uba Chupel, Luis Rama, et al.
Health & Justice|October 15, 2021
A rapid review of early guidance to prevent and control COVID-19 in custodial settingsLindsay A Pearce, Alaina Vaisey, Claire Keen, et al.
European Urology Oncology|September 22, 2020
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center StudyAndrew T Lenis, Aydin Pooli, Patrick M Lec, et al.
Anticancer Research|June 4, 2020
Neoadjuvant Treatment in Upper Rectal Cancer Does Not Improve Oncologic Outcomes But Increases Postoperative MorbidityNicolas Tabchouri, Yassine Eid, Gilles Manceau, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Pageof 57